Cargando…
Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cells
Estrogen receptor (ER) α is expressed in a subset of patient-derived acute myeloid leukemia (AML) cells, whereas Akt is predominantly expressed in most types of AML. Targeting AML with dual inhibitors is a novel approach to combat the disease. Herein, we examined a novel small molecule, 3-(4-isoprop...
Autores principales: | SHAHRANI, MESFER AL, RAJAGOPALAN, PRASANNA, ABOHASSAN, MOHAMMAD, ALSHAHRANI, MOHAMMAD, ALRAEY, YASSER, GAHTANI, REEM M., RADHAKRISHNAN, SURESH, DAGREERY, KHLOOD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tech Science Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207952/ https://www.ncbi.nlm.nih.gov/pubmed/37304671 http://dx.doi.org/10.32604/or.2022.03539 |
Ejemplares similares
-
CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways
por: Al Shahrani, Mesfer, et al.
Publicado: (2022) -
8-Ethoxy-3-(4-isopropylbenzylidene)-6-methylchroman-4-one
por: Marx, A., et al.
Publicado: (2007) -
3-Benzylidene-6-methoxychroman-4-one
por: Augustine, T., et al.
Publicado: (2008) -
2-(4-Isopropylbenzylidene)propanoic acid
por: Muhammad, Niaz, et al.
Publicado: (2008) -
N-[4-(Dimethylamino)benzylidene]-4-ethoxyaniline
por: Wang, Qiang, et al.
Publicado: (2007)